GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Syngene International Ltd (NSE:SYNGENE) » Definitions » Other Operating Expense

Syngene International (NSE:SYNGENE) Other Operating Expense : ₹19,141 Mil (TTM As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Syngene International Other Operating Expense?

Syngene International's Other Operating Expense for the three months ended in Mar. 2024 was ₹4,983 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₹19,141 Mil.

Syngene International's quarterly Other Operating Expense increased from Sep. 2023 (₹4,755 Mil) to Dec. 2023 (₹4,803 Mil) and increased from Dec. 2023 (₹4,803 Mil) to Mar. 2024 (₹4,983 Mil).

Syngene International's annual Other Operating Expense increased from Mar. 2022 (₹12,323 Mil) to Mar. 2023 (₹15,994 Mil) and increased from Mar. 2023 (₹15,994 Mil) to Mar. 2024 (₹19,141 Mil).


Syngene International Other Operating Expense Historical Data

The historical data trend for Syngene International's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syngene International Other Operating Expense Chart

Syngene International Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9,031.00 11,089.00 12,323.00 15,994.00 19,141.00

Syngene International Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,779.00 4,600.00 4,755.00 4,803.00 4,983.00

Syngene International Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹19,141 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Syngene International Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Syngene International's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Syngene International (NSE:SYNGENE) Business Description

Traded in Other Exchanges
Address
Jigani Link Road, Biocon SEZ, Biocon Park, Plot No. 2 and 3, IV Phase, Bommasandra Industrial Area, Bangalore, KA, IND, 560 099
Syngene International Ltd is a contract research and manufacturing organization in India. It supports research and development programs, from lead generation to clinical and commercial supplies. The company operates in India, the United States of America and other countries, of which a majority of the revenue is derived from the US. The company receives revenue by providing contract research and manufacturing services. It offers services such as Oligonucleotide synthesis, Bioinformatics, Clinical development services, polymer research, chemical development, safety assessment, discovery chemistry, discovery biology, and others.

Syngene International (NSE:SYNGENE) Headlines

No Headlines